Literature DB >> 6794745

Effects of diet and gliclazide on the haemostatic system of non-insulin-dependent diabetics.

R C Paton, P B Kernoff, J K Wales, G P McNicol.   

Abstract

The effect of the sulphonylurea gliclazide on tests of haemostatic function was studied in 14 newly diagnosed non-insulin-dependent diabetics. After two months' treatment with diet alone 11 of the 14 were given gliclazide; the three others remained on dietary treatment. Compared with pretreatment values, significant reductions in platelets retention, factor VIII-related antigen, factor VIII coagulant activity, and plasma heparin neutralising activity accompanied a fall in the plasma glucose concentration due to either diet alone or diet and gliclazide. The beneficial effects of gliclazide on platelet abnormalities seem likely to be due to its hypoglycaemic action rather than to any direct effect on haemostatic function.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6794745      PMCID: PMC1507242          DOI: 10.1136/bmj.283.6298.1018

Source DB:  PubMed          Journal:  Br Med J (Clin Res Ed)        ISSN: 0267-0623


  20 in total

1.  Anti-platelet effects of long-term treatment with gliclazide in diabetic patients.

Authors:  O Ponari; E Civardi; S Megha; M Pini; D Portioli; A G Dettori
Journal:  Thromb Res       Date:  1979       Impact factor: 3.944

2.  Pathogenesis of the coagulation defect developing during pathological plasma proteolytic ("fibrinolytic") states. II. The significance, mechanism and consequences of defective fibrin polymerization.

Authors:  N ALKJAERSIG; A P FLETCHER; S SHERRY
Journal:  J Clin Invest       Date:  1962-04       Impact factor: 14.808

3.  Studies on the nature of the circulating anticoagulant directed against antihemophilic factor: with notes on an assay for anthemophilic factor.

Authors:  R T BRECKENRIDGE; C D RATNOFF
Journal:  Blood       Date:  1962-08       Impact factor: 22.113

4.  A new method for the determination of fibrinogen in small samples of plasma.

Authors:  O D RATNOFF; C MENZIE
Journal:  J Lab Clin Med       Date:  1951-02

5.  Diabetes mellitus: a new look at diagnostic criteria.

Authors:  H Keen; R J Jarrett; K G Alberti
Journal:  Diabetologia       Date:  1979-05       Impact factor: 10.122

6.  Immunochemical quantitation of antigens by single radial immunodiffusion.

Authors:  G Mancini; A O Carbonara; J F Heremans
Journal:  Immunochemistry       Date:  1965-09

Review 7.  Plasma levels of beta-thromboglobulin and platelet factor 4 as indices of platelet activation in vivo.

Authors:  K L Kaplan; J Owen
Journal:  Blood       Date:  1981-02       Impact factor: 22.113

8.  Quantitative estimation of proteins by electrophoresis in agarose gel containing antibodies.

Authors:  C B Laurell
Journal:  Anal Biochem       Date:  1966-04       Impact factor: 3.365

9.  Haemostatic changes in diabetic coma.

Authors:  R C Paton
Journal:  Diabetologia       Date:  1981-09       Impact factor: 10.122

Review 10.  Hematologic alterations in diabetes mellitus.

Authors:  R L Jones; C M Peterson
Journal:  Am J Med       Date:  1981-02       Impact factor: 4.965

View more
  7 in total

1.  Treatment of type II diabetes.

Authors:  M Nattrass
Journal:  Br Med J (Clin Res Ed)       Date:  1986-04-19

2.  Oral hypoglycaemic agents.

Authors:  N Peden; R W Newton; J Feely
Journal:  Br Med J (Clin Res Ed)       Date:  1983-05-14

Review 3.  Gliclazide. A preliminary review of its pharmacodynamic properties and therapeutic efficacy in diabetes mellitus.

Authors:  B Holmes; R C Heel; R N Brogden; T M Speight; G S Avery
Journal:  Drugs       Date:  1984-04       Impact factor: 9.546

Review 4.  Gliclazide. An update of its pharmacological properties and therapeutic efficacy in non-insulin-dependent diabetes mellitus.

Authors:  K J Palmer; R N Brogden
Journal:  Drugs       Date:  1993-07       Impact factor: 9.546

Review 5.  Adverse cardiovascular effects of sulphonylurea drugs. Clinical significance.

Authors:  R Huupponen
Journal:  Med Toxicol       Date:  1987 May-Jun

Review 6.  Sulphonylurea treatment of NIDDM patients with cardiovascular disease: a mixed blessing?

Authors:  G Leibowitz; E Cerasi
Journal:  Diabetologia       Date:  1996-05       Impact factor: 10.122

7.  Plasma t-PA and PAl-1 antigen concentrations in non-insulin dependent diabetic patients: effects of treatment modality on fibrinolysis.

Authors:  Y W Cho; D H Yang; D Y Oh; S H Baick; S K Kim; S J Kim; S Y Hong
Journal:  Korean J Intern Med       Date:  1992-07       Impact factor: 2.884

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.